Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States
- PMID: 1370844
- PMCID: PMC265007
- DOI: 10.1128/jcm.30.1.126-131.1992
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States
Abstract
In this study, we compared sera from 159 human immunodeficiency virus type 1 (HIV-1)-infected individuals from Tanzania and 103 infected individuals from the United States for antibodies reactive with 10 HIV-1 gp160 epitopes defined by synthetic peptides. Our data indicate that the anti-gp160 antibody fine specificity differs between infected individuals from these two geographically diverse populations. For example, 50% of the Tanzanian sera contained antibodies reactive with an immunodominant HIV-1 gp41 epitope defined by peptide 600-611, whereas 91% of the sera from the United States were reactive. Differences in serologic reactivity between HIV-1-infected individuals from Tanzania and the United States were also observed with gp160 epitopes defined by peptides 503-528 and 846-860. Included among the peptides examined were four which corresponded to the V3 region of gp120. The majority of sera from either country contained antibodies reactive with peptide RP142, whose V3 sequence is based upon that of HIV-1 isolate MN. Further characterization of serologic reactivity suggested that sera from Tanzania were more likely to neutralize HIV-1 isolate IIIB or MN in vitro than were sera from the United States. These differences in antibody fine specificity between HIV-1-infected individuals from Tanzania and the United States suggest that regional isolates of HIV-1 may exist.
Similar articles
-
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.J Virol. 1992 Sep;66(9):5210-5. doi: 10.1128/JVI.66.9.5210-5215.1992. J Virol. 1992. PMID: 1380094 Free PMC article.
-
Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from Tanzania.J Med Virol. 1992 May;37(1):61-6. doi: 10.1002/jmv.1890370111. J Med Virol. 1992. PMID: 1619399
-
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002. AIDS. 1993. PMID: 8363754
-
Antigenic and immunogenic sites of HIV-2 glycoproteins.Chem Immunol. 1993;56:61-77. doi: 10.1159/000319156. Chem Immunol. 1993. PMID: 8452654 Review.
-
Blood banking in the United Republic of Tanzania.Transfus Apher Sci. 2023 Oct;62(5):103799. doi: 10.1016/j.transci.2023.103799. Epub 2023 Aug 24. Transfus Apher Sci. 2023. PMID: 37640603 Review. No abstract available.
Cited by
-
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.J Clin Microbiol. 1996 Apr;34(4):886-91. doi: 10.1128/jcm.34.4.886-891.1996. J Clin Microbiol. 1996. PMID: 8815102 Free PMC article.
-
Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.J Clin Microbiol. 1995 Feb;33(2):481-3. doi: 10.1128/jcm.33.2.481-483.1995. J Clin Microbiol. 1995. PMID: 7714212 Free PMC article.
-
Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes.Clin Exp Immunol. 1994 Jun;96(3):491-9. doi: 10.1111/j.1365-2249.1994.tb06056.x. Clin Exp Immunol. 1994. PMID: 7516272 Free PMC article.
-
Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein.Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):631-5. doi: 10.1073/pnas.92.2.631. Proc Natl Acad Sci U S A. 1995. PMID: 7831341 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical